Correction to: Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States

Infect Dis Ther. 2022 Feb;11(1):127. doi: 10.1007/s40121-021-00583-8.
No abstract available

Publication types

  • Published Erratum